TriSalus annual meeting elects two directors, ratifies auditor, approves say-on-pay frequency

TriSalus Life Sciences, Inc.

Mary Szela and Gary Gordon elected to three-year director terms with ~92% for votes.
Grant Thornton LLP ratified as independent auditor for fiscal 2026.
Advisory vote on exec compensation approved; board adopts three-year frequency for future votes.
Turnout: 67.9% of outstanding shares represented at the meeting.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.